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Abstract- In this review, we focus on cyclic voltammetry as a reliable electrochemical 
technique to study mechanisms, kinetics and thermodynamics of various types of drug-drug 
interactions. While we present and discuss six theoretical models relevant to analyze drug-drug 
(or drug-DNA) interactions, we also give hints about recent experimental achievements in this 
field. In addition, we provide the readers several sets of simulated voltammograms and data in 
tabular form, which can be used to recognize particular mechanism of drug-drug interactions 
in cyclic voltammetry. Moreover, we give hints to the voltammetric procedures that allow 
access to kinetics and thermodynamics parameters, which are relevant to various types of drug-
drug interactions. The results we present in this work can be of big help to the scientists working 
in the field of pharmacy, pharmacology, medicinal chemistry and bio-electrochemistry.  
Keywords- Cyclic voltammetry; Thermodynamics of drug-drug interactions; Kinetics of drug-
drug interactions; Stability constant of complexes; Electrode mechanisms  
 
 
1. INTRODUCTION  
Administration of a given drug in combination with another drug can lead to significant 
interactions between the active compounds. Information about strength of drug-drug 
interactions, and the pharmacokinetic features of defined drugs, can help to define most suitable 
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way of their administration. By analyzing the chemical interactions between two drugs, we can 
get information about stability, efficiency and the possible toxic effects related to the 
combination of drugs we administrate. When interactions between two drugs (or a given drug 
and DNA) are considered, one should always get information about: (a) mechanism of 
interactions between the drugs and the factors affecting the strength of drug-drug interactions; 
(b) kinetics of drug-drug interactions; (c) thermodynamics of drug-drug interactions. While the 
thermodynamic parameters relevant to drug-drug interactions give information about the 
magnitude of equilibrium (stability, or binding) constant, the kinetics of the interactions 
between two drugs can reveal information relevant to possible synergetic or antagonistic 
effects. In the last 40 years, voltammetry became a simple, fast, cheap and reliable tool for 
getting insight into mechanisms, kinetics and thermodynamics of interactions of many drugs 
[1-4]. We also witness that cyclic voltammetry (CV) is particularly suitable electrochemical 
techniques to analyze the drug-drug interactions from various aspects [1-3, 5]. In this short 
review we present: (a) theoretical results from mathematical models in CV, relevant to study 
mechanisms, kinetics and thermodynamics of drug-drug interactions and (b) experimental 
achievements performed by CV in analysis of some drug-drug or drug-DNA interactions. We 
consider systems in which interactions between two hydrophilic drugs occur, but also systems 
where one highly lipophilic and one hydrophilic drug undergo a chemical reaction. As we 
present several sets of voltammograms simulated for all relevant mechanisms considered, we 
also give hints to the theoretical methodologies proposed to analyze various drug-drug 
interactions. The results presented in this work are quite relevant for all experimentalists 
working in the field of drug-drug interactions studied with electrochemical techniques. Since 
there are plenty of review works dedicated to various amperometric biosensors for 
pharmaceutical applications, we skip in this mini-review elaborating papers concerned about 
construction of biosensors designed for drug quantification.  
 
2. DISCUSSION 
2.1. Theoretical models relevant to analyze drug-drug and drug-DNA interactions in 
cyclic voltammetry 
We consider in this part several electrode mechanisms that are relevant to describe 
interactions between two drugs. Under the term “electroactive” or (electrochemically active) 
we define a drug or a drug-metabolite (the last is generated chemically or electrochemically) 
that can undergo electrochemical transformation at the working electrode surface. When we 
use the term “electrochemically inactive”, we will consider a defined participant in an electrode 
mechanism that does not show electrochemical activity in the range of applied potentials. The 
symbol “C” at all mechanisms comprises “chemical reaction”, while the symbol “E” stands for 
“electrochemical reaction”. The term C’ denotes so-called “catalytic (regenerative) chemical 
Anal. Bioanal. Electrochem., Vol. 12, No. 3, 2020, 345-364                                                 347 
 
reaction”. The term “diffusional” means that the mass transfer of electroactive species occurs 
via diffusion only. The term “surface” suggests that the electroactive species are strongly 
adsorbed at the working electrode surface and there is no mass transfer taking place by 
diffusion. With “Ox” we assign the oxidized electroactive form of a given drug or metabolite, 
while “Red” stands for the reduced electroactive form. We use the symbols “A”, “Y” and “S” 
to assign electrochemically inactive drugs (or DNA) that can enter in some type of chemical 
interactions with the electrochemically active forms of the  drug (Ox or Red). In mechanisms 
3 and 6, we assume that “S” and “Y” drugs do not react between them. In mechanisms 4, 5 and 
6 we suppose that there are no chemical interactions between the adsorbed species. Terms “aq” 
and “ads” stand for aqueous solution (dissolved in water) and adsorbed state, respectively. At 
all considered mechanisms we assume that reversible chemical reactions are coupled to the 
“quasi-reversible” (kinetically controlled) electrochemical step. The assignation and schematic 
representation of the elaborated mechanisms is as follows:  
 
 
 
 
 
 
In all considered mechanisms, kf is the rate constant of forward chemical reaction, while kb 
is the rate constant of backward chemical step. With ksϴ we assign the standard rate constant 
of electron transfer related to reaction of electrode transformation (units of ksϴ are cm s-1 at 
diffusional mechanisms, and s-1 at surface mechanisms). It is worth to emphasize that in all 
elaborated mechanisms, the chemical rate constants are considered to be of pseudo first order. 
This means that we have one of the electrochemically inactive drugs (“A”, “S” or “Y”) present 
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in large excess in voltammetric cell. In all mechanisms, we assume constant values of 
parameters related to the electron transfer step (electron transfer coefficient α=0.5; diffusion 
coefficients of both Ox and Red is equal to D=5×10-6 cm2s-1). Dimensionless kinetic parameter 
related to electron transfer step KET is defined as: KET=ksϴ τ0.5D-0.5 at all diffusional mechanisms 
(1-3), and KET = ksϴτ at all surface electrode mechanisms (4-6). All simulations in this work 
are performed at constant measuring time of potential steps τ=0.01s. This implies that we 
consider experiments in which scan rate is kept constant, and the rate of chemical reactions is 
modified via altering concentration of electrochemically inactive drugs “A”, “Y”, or “S”.  
At this point, it is worth to emphasize that the current we measure in voltammetry (under 
the applied potential) is due to reaction Ox + ne- ↔ Red (i.e. due to exchange of electrons 
between working electrode and the electroactive drugs species). However, the chemical 
changes in concentrations of Ox and Red that will occur in the time frame of current measuring 
windows, commonly cause specific features at the recorded cyclic voltammograms. Indeed, 
the features of current-potential curves of every considered mechanism will depend on the 
current-measuring time scale, on the nature of chemical reaction, and on the kinetics and 
thermodynamics parameters related to the chemical step. At the beginning of the theoretical 
part, we elaborate some of the most relevant theoretical features of all considered mechanisms 
under conditions of cyclic staircase voltammetry. In so-called “surface” electrode mechanisms 
4-6, we assume that the redox active forms of the drugs Ox(ads) and Red(ads) are strongly 
adsorbed (ads) at the working electrode surface, and there is no mass transfer occurring via 
diffusion. In addition, we assume that there are no interactions between the adsorbed species.  
2.1.1. Diffusional CE mechanism  
This specific electrode mechanism is met when a chemical conversion of initial 
electrochemically inactive drug “A” creates a water-soluble electrochemically active reactant 
Ox. For constant scan rate, and for constant molar concentration of drug “A”, the voltammetric 
features of this electrode mechanism depend on two dimensionless parameters related to the 
chemical step: (a) the value of equilibrium constant Keq = kf/kb; and (b) the kinetic of the 
chemical reaction expressed via dimensionless chemical parameter Kchemical, defined as  
Kchemical = (kf+kb)τ. While the value of Keq defines the initial amount of Ox available for 
electrode transformation, the magnitude of chemical parameter Kchemical reflects the influence 
of the rate of chemical reaction relative to the time scale of voltammetric measurements τ. 
Actually, in experiments where one is concerned to quantify the drug-drug interactions, 
determination of the values of Keq and Kchemical (i.e. kf and kb) is a crucial segment. These 
parameters are directly related to the strength of interactions (via kf and kb), and to the 
magnitude of thermodynamic constant of given drug-drug chemical equilibrium (via Keq). If 
Keq > 100, we get unperturbed cyclic voltammograms as of a simple electrode reaction Ox(aq) 
+ ne- ↔ Red(aq). Under such conditions, initial amount of Ox(aq) created via chemical 
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preceding reaction is large enough, so the kinetics of preceding chemical reaction does not play 
any significant role in the current-measuring time segment at potential steps. If Keq ≤1, then 
we witness obvious effects of the kinetics of preceding chemical step to the features of 
simulated voltammetric patterns. Shown in figure 1 and 2 is a series of cyclic voltammograms 
of a diffusional CE mechanism, simulated for Keq of 0.0001 (Figure 1) and Keq of 0.15  
(Figure 2).  
 
 
 
 
 
 
 
 
 
Figure 1. Influence of the chemical parameter Kchemical to the features of cyclic voltammograms 
of a diffusional CE mechanism simulated for small value of equilibrium constant Keq = 0.0001. 
Value of dimensionless kinetic parameter of electron transfer was KET = 0.5, electron transfer 
coefficient was set to α= 0.5, height of potential step was dE = 4 mV; duration of potential step 
was τ = 0.01 s, temperature T = 298 K, while the diffusion coefficient of Ox and Red were set 
to equal value of D = 0.000005 cm2s-1. The value of chemical rate parameter Kchemical were: 40 
(a); 140 (b); 240 (c); 340 (d) and 440 (e). 
 
Voltammetric patterns in figure 1 are simulated at high rates of the preceding chemical step. 
Under such circumstances, cyclic voltammograms feature well-developed anodic (oxidative) 
current component, and a steady-state (plateau-like) forward (reductive) current branch. This 
voltammetric feature is typical for CE systems with Kchemical × Keq > 10, but for Keq < 0.01. In 
such scenario, the magnitude of limiting currents corresponding to the plateau-Ilimiting is 
proportional to (Kchemical)0.5, and independent on scan rate. In this kinetic region, the slope of 
Ilimiting vs.  (Kchemical)0.5 equals to: nFSc*(τ-1DKeq)0.5. The dependence between Ilimiting vs.  
(Kchemical)0.5 can be explored for the determination of Keq, as described in [2, 5-7], providing 
that value of diffusion coefficients of Ox and Red (D) is known. The value of Keq can be also 
accessed from the slope of the dependence of mid-peak potentials Emid,p vs. log(Kchemical), in 
regions of Keq < 10, and at high values of Kchemical as described in [2, 6, 7].  
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Figure 2. Influence of the chemical parameter Kchemical to the features of cyclic voltammograms 
of a diffusional CE mechanism simulated for value of equilibrium constant Keq = 0.15. Other 
simulation parameters were same as those in figure 1. Values of the chemical rate parameter 
Kchemical are given in the graphs. 
 
If Keq is small (Keq < 0.1), and if rate of chemical step is also small (Kchemical < 0.1), then the 
current is governed by the electrode reaction Ox(aq) + ne- ↔ Red(aq). Under such 
circumstances, the value of the mid-peak potential Emid,p shifts for (-59mV/n) per every tenfold 
increase of Kchemical [2, 6], with intercept of that dependence being equal to: EϴOx/Red + 
(0.059V/n)log[Keq/(1+Keq)]. The intercept of Emid,p vs. log(Kchemical) dependence in this kinetic 
region can give access to the magnitude of Keq, providing that the value of EϴOx/Red is known. 
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In case of moderate values of Keq, the chemical parameter Kchemical produces complex 
phenomena to voltammetric patterns, as presented in figure 2. In such scenario, there is a mixed 
kinetic control, and we have to make a “two-parameter fitting procedure” [2] or we have to 
know Keq from independent experiments (spectrophotometric, for example) in order to 
evaluate the magnitude of chemical rate parameter Kchemical [2, 6].   
 
2.1.2. Diffusional CE mechanism  
This mechanism is met when an electrochemically generated drug-product Red(aq) enters 
in a follow-up chemical reaction with an electrochemically inactive drug “Y” in a reversible 
fashion. We designate this system as “diffusional ECrev mechanism” (or simply EC 
mechanism), providing that the mass transfer of Ox and Red to the working electrode takes 
place via diffusion. For constant values of the diffusional coefficients of Ox and Red, and at 
constant scan rate, the features of calculated cyclic voltammograms depend on dimensionless 
parameters Keq and Kchemical. These parameters are defined identically as for diffusional CE 
mechanism elaborated in previous section. If the equilibrium constant is large (i.e. Keq > 100), 
then the entire mechanism turns to ECirr, or electrochemical reaction coupled with irreversible 
chemical reaction. In that scenario, an increase of Kchemical produces voltammetric patterns as 
those depicted in Figure 3. Any increase of Kchemical in the region Kchemical > 0.001 (for Keq > 
100) leads to diminishment of the current of backward (reoxidation) branch of cyclic 
voltammograms. The ratio between anodic Ip,a and cathodic Ip,c peak  current features sigmoidal 
dependence on log(Kchemical). Obtained sigmoidal curves of Ip,a/Ip,c vs. log(Kchemical) can be used 
for the determination of Kchemical. In the kinetic region, the mid-peak potential of cyclic 
voltammograms shifts 59 mV/n for a tenfold increase of Kchemical. For small and moderate 
values of Keq, we observe a sigmoidal dependence of Emid,p vs. log(Kchemical), with linear parts 
of the curves having slopes of -59 mV/n, and intercepts that are function of Keq. The slope of 
Emid,p vs. log(Kchemical) in kinetic region is defined as: EϴOx/Red+[2.3RT/(nF)] log(1+Keq). The 
last parameter can be explored for the determination of Keq, if the value of EϴOx/Red is known 
[2]. In the case when Keq < 1, and Kchemical > 0.1, one observes complex kinetically controlled 
voltammetric patterns. Under such conditions, only by “two-parameters fitting” procedure [2] 
one can get access to Kchemical and Keq. 
 
2.1.3. Diffusional EC’ mechanism  
The catalytic EC’ mechanism coupled with an irreversible chemical reaction is considered 
as a very suitable model to study interactions between many drugs and other physiologically 
important substances [2, 5, 7-23]. We elaborate here a more comprehensive type of 
Electrochemical-Catalytic i.e., the ECrev’ mechanism, where we suppose a reversible chemical 
Anal. Bioanal. Electrochem., Vol. 12, No. 3, 2020, 345-364                                                 352 
 
step coupled to electrode reaction. The mechanism we consider provides access not only to the 
kinetics, but also to thermodynamics of drug-drug interactions, as reported in [24, 25].  
 
 
 
Figure 3. Influence of the chemical parameter Kchemical to the features of cyclic voltammograms 
of a diffusional EC mechanism simulated for value of equilibrium constant Keq = 1000. Other 
simulation parameters were same as those in Figure 1. Values of the chemical rate parameter 
Kchemical are given in the graphs. 
 
In this mechanism, we assume both “electroactive” compounds (the two redox forms of 
same drug) to enter into a reversible chemical interconversion from the beginning of 
experiment, even before potential is applied. We assume that Ox(aq) undergoes selective 
chemical reaction with the substrate (drug) “S”, and creates compounds Red(aq) and “Y” in a 
chemically reversible manner. Indeed, Red(aq) can be also generated electrochemically from 
Ox(aq), under conditions of applied potential. We suppose that electroactive drug Red(aq) also 
undergoes a regenerative (chemically reversible) reaction with “Y” (present in large excess as 
dissolved species in solution). Chemical reaction between Red(aq) and Y(aq) regenerates the 
initial electroactive drug Ox(aq) and the substrate “S”. We define “Y” and “S” as 
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“electrochemically inactive drugs”, and we suppose that both do not show electrochemical 
activity in the window of applied potentials. We also assume that “S” and “Y” do not react 
between them. A limiting situation of considered catalytic reversible EC’rev mechanism is the 
catalytic irreversible EC’irr mechanism, obtained for Keq > 100 [24, 25]. At constant scan rate 
and for defined parameters related to the electron transfer step of electrode reaction (ksϴ, D and 
α), the cyclic voltammograms of this specific mechanism are function of equilibrium constant 
Keq, and of dimensionless catalytic parameter Kcatalytic = (kf + kb)τ. The last parameter is related 
to the rate of chemical reaction vs. the measuring time at potential steps. In scenario of large 
concentrations of “S” or “Y”, the forward and backward rate constants of chemical reaction kf 
and kb are linked to the bulk substrates concentrations as: kf = kf’ c(S) and kb = kb’ c(Y). This 
implies that in real experiments, Kcatalytic can be modified by altering molar concentrations of 
substrates S or Y. 
 
 
 
Figure 4. Cyclic voltammograms of diffusional catalytic EC’rev mechanism calculated for 
value of equilibrium constant Keq=1000, and for values of catalytic parameter Kcatalytic=0.3 (a), 
0.5 (b), 1 (c) and 100 (d). The value of dimensionless kinetic parameter of electrode reaction 
was set to KET=0.1. The other simulation parameters were same as in Figure 1. 
 
Cyclic voltammograms calculated for KET = 0.1, Keq=1000, and for several values of 
Kcatalytic are presented in Figure 4. Voltammetric patterns of reversible EC’rev mechanism, 
simulated under such conditions, have features identical as of “simple” electrochemical 
catalytic EC’ mechanism associated with irreversible chemical step [2, 5-7]. If Kcatalytic is small 
relative to current-measuring time-scale, observed cyclic voltammograms have quasi-
reversible features, with the peak current ratio between the cathodic and anodic peaks ≈ 1 
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(voltammogram 1 at Figure 4). As the rate of catalytic reaction increases, we observe increasing 
in the current of the forward peak and a concomitant decrease of the backward currents. At 
large values of Kcatalytic, significant amount of Ox will be chemically regenerated during the 
current-measuring time of given potential steps. This scenario will result in voltammetric 
shapes that get transition features between diffusion controlled and a steady-state behavior 
(curves 2-3 in Figure 4).  Another feature of this mechanism is seen in the elevation of the 
“after-peaks” currents recorded at negative potentials. For Kcatalytic > 0.2, the oxidation current 
branch gets lost, and both current components get identical sigmoidal shape that is typical for 
steady-state voltammograms (curve 4 in Figure 4). This happens when the rate of chemical 
regenerative reaction gets much faster than the rate of the re-oxidation electrode step. Under 
such circumstances, we get multiple occurrence of the Ox + ne-→Red electrochemical reaction 
at all potentials. In such scenario, both current branches will be reduction currents, and the 
voltammetric patterns will get steady-state features [2, 5-14].  
 
 
Figure 5. Cyclic voltammograms of diffusional catalytic EC’rev mechanism calculated as a 
function of equilibrium constant of regenerative chemical reaction Keq. Keq was set to: 0.1 (a); 
0.0316 (b) 0.01 (c) and 0.0001 (d). Curves are simulated for value of catalytic parameter 
Kcatalytic= 0.0316. The value of dimensionless kinetic parameter of electrode reaction was set to 
KET =0.5. Other simulation conditions were same as those in Figure 1. 
 
Under conditions of steady-state voltammograms, the magnitude of limiting current 
(Ilimiting) (“plateau” current) of cyclic steady-state voltammograms is affected only by the rate 
of regenerative chemical reaction and it is a linear function of (Kcatalytic)0.5. The relationship 
between the Ilimiting and (Kcatalytic)0.5 can be explored for quantitative purposes, but also for 
determination of the kinetics of drug-drug interactions as elaborated in [5-8, 11-14, 24, 25]. 
Other remarkable features of this catalytic EC’ mechanism are recognized in the role of 
equilibrium constant of regenerative chemical step. As we know, the equilibrium constant of 
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regenerative step Keq determines the ratio of Ox and Red species available to undergo 
electrochemical transformation. Consequently, we expect that Keq should influence all relevant 
features of cyclic voltammograms. Effect of Keq to the cyclic voltammograms of this 
mechanism is illustrated in Figure 5. We can observe from patterns in Figure 5 that Keq affects 
all relevant parameters of the cyclic voltammograms, i.e. the height of the peaks, the peak-to-
peak separation (∆Ep = |(Ep,c-Ep,a)|), and the currents magnitudes measured at the negative 
potentials. For values of Kcatalytic > 0.2 a regular shift of the half-wave potential E1/2 in negative 
direction is observed. The dependence between E1/2 and Kcatalytic can be explored for 
determination of standard rate constant of electron transfer, and for equilibrium constant Keq, 
as explained in [5-7, 25]. 
 
2.1.4. Surface CE, EC and EC’ mechanism  
The surface mechanisms coupled with chemical equilibria elaborated in this work are 
relevant to the voltammetric behavior of lipophilic drugs whose both redox forms (Ox and Red) 
are strongly adsorbed at the working electrode surface. Voltammetric patterns of all considered 
surface mechanisms have several specific features that can be shortly summarized in: a) sharper 
cathodic and anodic peaks than the corresponding peaks at diffusional mechanism; b) absence 
of diffusional tail; c) voltammetric features susceptible to lower chemical rates than by 
corresponding diffusional mechanisms; d) linear dependence of the limiting currents (in 
mechanisms 4 and 6) as a function of Kchemical. 
The dimensionless kinetic parameter related to the electron transfer step at all surface 
mechanisms is defined as KET=ksϴτ. The kinetic and thermodynamic parameters related to the 
chemical steps in all surface mechanisms are defined identically as at corresponding diffusional 
mechanisms. Since the chemical parameters Kchemical and Keq cause similar effects to the 
voltammetric patterns as in the corresponding diffusional mechanisms 1-3, we present in 
Figures 6-8 only representative sets of simulated voltammograms of all considered surface 
mechanisms. In respect to the corresponding diffusional mechanisms, remarkable differences 
exist in the dependence of limiting currents Ilimiting at surface CE and surface EC’ mechanisms. 
At surface CE and the EC’ mechanism, the limiting currents Ilimiting of cyclic voltammograms 
(recorded in the kinetic regions) are proportional to Kchemical. Recall that at diffusional CE and 
EC’ mechanisms, Ilimiting was linear function of (Kchemical)0.5. More comprehensive discussions 
about features of surface CE, EC and EC’ mechanisms under conditions of cyclic voltammetry 
can be found in [2, 26]. In Table 1 we give data about the determination of relevant chemical 
parameters at all considered mechanisms, which can be used to characterize given drug-drug 
interactions. Moreover, in the same table we give short description about the specific 
voltammetric features that are caused by the rate of corresponding chemical reaction. At this, 
it is worth to mention once again that we assume in our models experiments performed at 
constant scan rates. In such scenarios, variation of chemical parameter Kchemical can be achieved 
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via modification of concentration of substrate “Y”, while keeping at constant value all other 
parameters. 
 
Figure 6. Influence of the chemical parameter Kchemical to the features of cyclic voltammograms 
of a surface CE mechanism simulated for value of equilibrium constant Keq = 0.01. Value of 
dimensionless kinetic parameter of electron transfer was KET= 0.5. The values of chemical rate 
parameter Kchemical are given in the charts. Other simulation conditions were same as those in 
Figure 1. 
Anal. Bioanal. Electrochem., Vol. 12, No. 3, 2020, 345-364                                                 357 
 
 
Figure 7. Influence of the chemical parameter Kchemical to the features of cyclic voltammograms 
of a surface EC mechanism simulated for value of equilibrium constant Keq= 1. Value of 
dimensionless kinetic parameter of electron transfer was KET= 0.5. The values of chemical rate 
parameter Kchemical are given in the charts. Other simulation conditions were same as those in 
Figure 1. 
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Figure 8. Influence of rate of chemical regenerative reaction to the features of theoretical cyclic 
voltammograms of a surface catalytic ECrev’ mechanism. Voltammograms are simulated for 
six values of Kcatalytic (values are given in the charts) for KET of 0.1, and for Keq= 1. The other 
parameters used in simulation model were identical as in figure 1. 
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Table 1. Description of the relevant voltammetric features at all considered mechanisms, and proposed methods 
for the determination of the kinetic and thermodynamic parameters related to the chemical steps 
 
Type of 
mechanism 
Definition of 
dimensionless 
chemical rate 
parameter  
Definition of 
equilibrium 
constant  
Some characteristic effects 
to cyclic voltammograms 
caused by an increase of 
chemical rate parameter 
Kchemical 
How to get access to 
Keq 
How to get access to Kchemical 
Diffusional 
CE  
Kchemical = 
(kf+kb)τ 
Keq= kf/kb -plateau-like feature of 
forward currents in 
region of small values of 
Keq 
-shift of the mid-peak 
potential in negative 
direction for (-59 mV/n) 
for every tenfold increase 
of Kchemical at systems 
with small and moderate 
value of Keq 
-from the intercept 
of dependence 
Emid,p vs. 
log(Kchemical) in 
kinetic region 
 
-via “two-
parameter fitting 
procedure” 
In the kinetic region, from the 
equation of limiting current Ilimiting 
that is defined as:  
Ilimiting= nFSc*[KchemicalDKeq /τ]0.5  
(values of Keq, D and initial 
concentration of reactant c* 
should be known) 
 
-via “two-parameter fitting 
procedure” 
Diffusional 
EC 
Kchemical = 
(kf+kb)τ 
Keq= kf/kb -permanent 
diminishment of 
backward peak current 
by increasing of 
Kchemical in the kinetic 
region 
-shift of the mid-peak 
potential in positive 
direction for (59 mV/n) 
for every tenfold increase 
of Kchemical at systems 
with small and moderate 
value of Keq 
 
-from the intercept 
of linear 
dependence Emid,p 
vs. log(Kchemical) in 
kinetic region 
 
-via “two-
parameter fitting 
procedure” 
From the Ip,a/Ip,c curve constructed 
as a function of  log(Kchemical) 
 
-via “two-parameter fitting 
procedure” 
Diffusional 
catalytic 
EC’rev 
Kchemical = 
(kf+kb)τ 
Keq= kf/kb -decrease of backward 
and concomitant increase 
of forward currents 
obtained by increasing of 
Kcatalytic 
 
-steady-state cyclic 
voltammograms 
featuring plateau are 
obtained at higher values 
of chemical rate 
parameter Kcatalytic 
 
-limiting current of 
cyclic voltammograms 
Ilimiting is a linear 
function of square-root 
of catalytic rate 
parameter (Kcatalytic)0.5 
 
-half-peak potential E1/2 
of steady-state 
voltammograms shifts in 
negative direction by 
increasing of Kcatalytic 
 
from the intercept 
of the mid-peak 
potential E1/2 as a 
function of 
log(Kcatalytic), 
(provided that 
standard redox 
potential EOx/Red is 
known) 
From the equation of Ilimiting vs. 
(Kcatalytic)0.5 linear dependence: 
Ilimiting =nFS[(c*(Ox) 
(DKcatalytic)0.5]/(τ)0.5  (initial 
concentration of Ox- c*(Ox) and 
diffusion coefficient D should be 
known) 
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Surface 
CE 
Kchemical = 
(kf+kb)τ 
Keq= kf/kb -forward currents get 
shape of plateau in 
region of small values of 
Keq by increasing Kchemical 
 
- In the kinetic region, 
limiting current Ilimiting is 
proportional to Kchemical 
 
-mid-peak potentials 
shift in negative direction 
for (-59 mV/n) for every 
tenfold increase of 
Kchemical at systems with 
small and moderate value 
of Keq 
 
-absence of diffusional 
tail at cyclic 
voltammograms 
from the intercept 
of dependence 
Emid,p vs. 
log(Kchemical) in 
kinetic region 
In the kinetic region, limiting 
current Ilimiting is defined as:  
Ilimiting= nFSI*(KchemicalKeq/τ) 
(one should know the values of 
Keq and I* are known) 
Surface 
EC 
Kchemical = 
(kf+kb)τ 
Keq= kf/kb -backward currents 
diminish by increasing of 
Kchemical 
-mid-peak potential 
shifts for (59 mV/n) for 
every tenfold increase of 
Kchemical at systems with 
small and moderate value 
of Keq 
- ratio Ip,a/Ip,c decreases 
by increasing of Kchemical 
-absence of diffusional 
tail at cyclic 
voltammograms 
-from the intercept 
of linear 
dependence Emid,p 
vs. log(Kchemical) in 
kinetic region (if 
EϴOx/Red is known) 
 
-via “two-
parameter fitting 
procedure” 
From the Ip,a/Ip,c curve constructed 
as a function of  log(Kchemical) 
 
-via “two-parameter fitting 
procedure” 
Surface 
catalytic 
EC’rev 
Kchemical = 
(kf+kb)τ 
Keq= kf/kb -decrease of backward 
and concomitant increase 
of forward currents 
obtained by increasing of 
Kcatalytic 
-steady-state cyclic 
voltammograms 
featuring plateau are 
obtained at higher values 
of chemical rate 
parameter Kcatalytic 
-limiting current of 
cyclic voltammograms 
Ilimiting is a linear function 
of catalytic rate 
parameter Kcatalytic 
-half-peak potential E1/2 
of steady-state 
voltammograms shifts in 
negative direction by 
increasing of Kcatalytic 
-absence of “diffusional 
tail” 
-from the intercept 
of the mid-peak 
potential E1/2 as a 
function of 
log(Kcatalytic), 
(provided that 
standard redox 
potential EOx/Red is 
known) 
From the equation of Ilimiting vs. 
(Kcatalytic) linear dependence: 
Ilimiting=nFS[I*(Ox) (Kcatalytic)/τ      
[27] 
 (initial surface concentration of 
Ox-I*(Ox) should be known) 
 
 
*S is the surface area of working electrode [cm2]; F is Faraday constant (96500 C/mol); τ is duration of potential step in cyclic staircase voltammetry 
(s); I*(Ox) is total surface concentration of Ox species [mol/cm2] 
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2.2. Experimental voltammetric studies on drug-drug and drug-DNA interactions 
In Table 2 we give experimental examples about some relevant chemical parameters of 
drug-drug and drug-DNA interactions evaluated by cyclic voltammetry. We focus on 
experimental works in this filed that are published mainly in last ten years.  
 
Table 2. Experimental parameters (evaluated from cyclic voltammetry) related to stability constants of 
drug-drug and drug-DNA interactions 
 
Drug-drug 
(or Drug-DNA) 
Experimental conditions Equilibrium 
(stability) constant Keq 
Ref. 
Novobiocin and cysteine pH of 5.00; 7.00; and 9.00; HMD electrode 3.06×103 M-1 (in pH of 5.0) 
1.06×105 M-1 (pH of 7.0) 
1.06×105 M-1 (pH of 9.0) 
[28] 
Anthracycline calf thymus DNA  pH = 7.00; Glassy carbon electrode 4.44×105 M-1 [29] 
Ortho 2-(5-fluoro-2,4 dioxo-3,4-
dihydroppyrimidin-1(2H)-yl)-N-
(pyridin-2-yl) acetamide-DNA 
pH = 7.16; Glassy carbon electrode 2.33×103 M-1 [30] 
Meta 2-(5-fluoro-2,4 dioxo-3,4-
dihydroppyrimidin-1(2H)-yl)-N-
(pyridin-2-yl) acetamide-DNA 
pH = 7.16; Glassy carbon electrode 6.60×103 M-1 [30] 
flutamide (4-nitro-3-
trifluoromethylisobutylanilide)-DNA 
pH = 7.00; CPE (carbon paste electrode)  - [31] 
moxifloxacin (MOXI) in tablets-Cu(II) 
ion 
pH = 8.00; HMDE - [32] 
Omeprazole-azithromycin pH = 7.40; Glassy carbon electrode 3.930 µM-1 [33] 
Omeprazole-clarithromycin pH = 7.40; Glassy carbon electrode 0.985 µM-1 [33] 
Omeprazole- roxithromycin pH = 7.40; Glassy carbon electrode 0.321 µM-1 [33] 
Omeprazole- doxycycline pH = 7.40; Glassy Carbon electrode 8.230 µM-1 [33] 
Doxorubicin (DXH)-DNA pH = 7.40; Glassy Carbon electrode 5.00×105 M-1 [34] 
Epirubicin (EpiDXH)-DNA pH = 7.40; Glassy Carbon electrode 0.11×105 M-1  [34] 
Daunorubicin (DNR)-DNA pH = 7.40; Glassy Carbon electrode 17.2×105 M-1 [34] 
Doxorubicin hydrochloride- calf thymus 
DNA 
pH = 7.40; Glassy carbon electrode 1.05×105 M-1 [35] 
Acetaminophen (paracetamol) - 
antidepressant drugs ((a) fluoxetine, (b) 
sertraline and (c) nortriptyline) 
pH = 7.0; Glassy carbon electrode - [36] 
Cobalt(III) Schiff Base Complex [trans-
[Co(salen)(DA)2]ClO4 -CT-DNA 
pH=7.40; Glassy carbon electrode 1.31×104 M−1 
 
[37] 
Cobalt(III) Schiff Base Complex  
trans-[Co(salophen)(DA)2]ClO4 (DA – 
dodecylamine)]- CT-DNA 
pH=7.40; Glassy carbon electrode 3.15×104 M−1 
 
[37] 
Dopamine (DA)- herring sperm 
deoxyribonucleic acid (ds-DNA) 
pH = 7.00; Glassy carbon electrode modified with 
silver-doped Poly Cysteine membrane 
1.08×105 M-1 [38] 
Epinephrine (Epi)-Fe3+ pH = 7.40; Boron-doped diamond electrode - [39] 
Epinephrine (Epi)-Fe2+ pH = 7.40; Boron-doped diamond electrode - [39] 
Cu(II) complex-DNA Glassy carbon electrode 27.5×104 M-1 [40] 
Zn(II) complex-DNA Glassy carbon electrode 64.5×104 M-1 [40] 
Ceftriaxone with phenylalanine pH = 7.00 ; Glassy carbon electrode 1.32×103 M-1 [41] 
Pyrimethamine with dsDNA pH = 7.00; Glassy carbon electrode 4×105 M-1 [42] 
[CuL2]Cl2xH2O where L= 1-amidino-O-
ethylurea with DNA 
pH = 7.20;  Pt electrode 1×104 M-1 [43] 
Noglamycin with DNA pH of 7.00; Glassy carbon electrode 4.44×105 M-1 [44] 
Ciprofloxacin with DNA pH = 7.00; Glassy carbon electrode modified with 
MWCNTs+DNA 
2.90×105 M-1 [45] 
Tyrosine with DNA pH = 7.00; Glassy carbon electrode 3.98×103 M-1 [46] 
Sulfadiazine with DNA pH = 7.00; Glassy carbon electrode modified with 
MWCNTs 
2.87×103 M-1 [47] 
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In most of the cases, a glassy carbon electrode, or carbon electrodes modified with nano-tubes 
are used as working electrodes. From the magnitudes of the stability constants in Table 2, we 
can see that experimentally determined Keq (or Kstability) values related to elaborated drug-
drug or drug-DNA complexes range between 103 and 106 M-1. These values of Keq imply 
moderate stability of studied drug-drug or drug-DNA complexes. This means that cyclic 
voltammetry gives very good results for Keq for complexes with small and moderate values of 
stability constants [2], which is proven in many of the experimental works elaborated in this 
review. 
 
3. CONCLUSION 
We shortly elaborate in this review six theoretical models in cyclic voltammetry that are 
relevant to study drug-drug and drug-DNA interactions from many aspects. As we present large 
sets of simulated cyclic voltammograms related to defined mechanisms coupled to particular 
chemical reaction, we also give hints to evaluate thermodynamic and kinetics parameters 
relevant to drug-drug or drug-DNA interactions. Our advice to experimentalists working in this 
field is to perform voltammetric experiments related to drug-drug interactions at constant scan 
rate. Under such conditions, the rate of chemical reactions in all mechanisms can be modified 
by varying the molar concentration of substrate “Y” in voltammetric cell. As explained 
explicitly in the theoretical part of this mini-review, in order to evaluate kinetic and 
thermodynamic parameters relevant to drug-drug interactions, we must “work” in so-called 
“kinetically controlled regions” of cyclic voltammograms. At all elaborated mechanisms, we 
can achieve this scenario by adjusting the duration of potential step τ in CV and by varying the 
molar concentration of electrochemically inactive drug (substrate) “Y”. In this way, we can 
create experimental conditions to reproduce the “kinetic” voltammetric patterns as those 
presented in figures 1 to 8. This will further allow estimation of Kchemical and Keq from the 
equations or dependences described in Table 1. This review shows that cyclic voltammetry can 
be seen as a fast, simple and reliable tool that can provide insight into various aspects of drug-
drug interactions. The major limitations of cyclic voltammetry come from complex adsorption 
phenomena and interfering compounds that commonly make complications at all electrode 
mechanisms. 
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